v3.26.1
Note 2 - Revenues
9 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

Note 2. Revenues

 

Revenue is measured based on consideration specified in the contract with a customer, adjusted for any applicable estimates of variable consideration and other factors affecting the transaction price. Estimates of variable consideration primarily relate to capped installment payment arrangements with third‑party payers and patient responsibility amounts, including deductibles, coinsurance, copayments, and similar amounts. Estimating variable consideration requires significant judgement, including selecting estimation methodologies, evaluating historical payment experience, and assessing factors that may affect future collections. Electromed estimates variable consideration using the expected value method, as it best predicts the amount of consideration to which Electromed expects to be entitled, given the large number of contracts with similar characteristics and a wide range of possible outcomes. In applying this method, management considers quantitative inputs such as historical claims approval rates, payment timing and recovery patterns, historical termination experience, and patient demographic data, as well as qualitative factors including changes in insurance coverage, mortality, patient utilization patterns, and other relevant circumstances.

 

Capped installment payment arrangements represent the majority of Electromed’s variable consideration. For the periods presented, amounts subject to capped installment payment arrangements represented a significant portion of net revenues, accounting for approximately 96% of net revenues in the homecare market. Electromed’s estimates of consideration related to these arrangements are based on historical payment and termination patterns and are subject to contractual caps that limit the total consideration to which Electromed may be entitled.

 

When a contract with a customer has been established, revenue is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to a customer, typically upon shipment or delivery. 

 

Disaggregation of revenues. In the following table, net revenues are disaggregated by market:

 

  

Three Months Ended March 31,

  

Nine Months Ended March 31,

 
  

2026

  

2025

  

2026

  

2025

 

Homecare

 $16,732,000  $14,102,000  $48,895,000  $41,906,000 

Hospital

  1,032,000   724,000   2,734,000   2,137,000 

Homecare distributor

  715,000   696,000   2,449,000   2,090,000 

Other

  96,000   162,000   281,000   474,000 

Total

 $18,575,000  $15,684,000  $54,359,000  $46,607,000 

 

In the following table, net homecare revenue is disaggregated by payer type:

 

  

Three Months Ended March 31,

  

Nine Months Ended March 31,

 
  

2026

  

2025

  

2026

  

2025

 

Commercial

 $8,190,000  $7,151,000  $23,346,000  $21,329,000 

Medicare

  6,447,000   5,126,000   19,035,000   15,371,000 

Medicare Supplemental

  1,559,000   1,314,000   4,618,000   3,813,000 

Medicaid

  256,000   238,000   1,034,000   676,000 

Other

  280,000   273,000   862,000   717,000 

Total

 $16,732,000  $14,102,000  $48,895,000  $41,906,000 

 

Contract balances. The following tables provide information about accounts receivable and contract assets from contracts with customers:

 

  

As of March 31, 2026

  

As of June 30, 2025

 

Receivables, included in “Accounts receivable, net of allowances for credit losses”

 $28,251,000  $24,660,000 

Contract Assets

 $1,086,000  $1,036,000 

 

Total Accounts receivable, net of allowances for credit losses, as of June 30, 2024, were $23,333,000. Accounts receivable outstanding for greater than one year totaled $473,000 and $430,000 as of March 31, 2026, and June 30, 2025, respectively. Our accounts receivable balance contains amounts due from governmental and other third-party payers, including Medicare. Under certain payer programs, cash collection occurs through interim payments and final settlement over a period greater than one year, generally approximating thirteen months. The Company has determined that this collection period represents its normal operating cycle. In accordance with ASC 210‑10‑45, the Company classifies these receivables as current assets.

 

  

Nine Months Ended

  

Fiscal Year Ended

 
  

March 31, 2026

  

June 30, 2025

 

Contract assets, beginning

 $1,036,000  $719,000 

Reclassification of contract assets to accounts receivable

  (1,411,000)  (2,577,000)

Contract assets recognized

  1,439,000   2,694,000 

Increase as a result of changes in the estimate of amounts to be realized from payers, excluding amounts transferred to receivables during the period

  22,000   200,000 

Contract assets, ending

 $1,086,000  $1,036,000